18 November 2024 - FoundationOne Liquid CDx is the first FDA approved companion diagnostic to identify patients who may be ...
24 October 2024 - Telix Pharmaceuticals today announces that the US FDA has accepted the new drug application for TLX101-CDx (Pixclara), ...
21 October 2024 - Oncomine Dx target test to identify patients eligible for Servier’s Voranigo (vorasidenib) tablet, the only FDA ...
27 September 2024 - The US FDA has approved Flyrcado (flurpiridaz F 18) in adult patients with known or suspected coronary ...
5 September 2024 - Perspective Therapeutics today announced that the US FDA granted fast track designation for the development of ...
27 August 2024 - TruSight Oncology Comprehensive is the first US FDA approved, distributable comprehensive genomic profiling Iin vitro diagnostic kit ...
28 August 2024 - Life Molecular Imaging is pleased to announce that the US FDA granted fast track designation to [18F]PI-2620 ...
28 August 2024 - Telix today announces it has submitted a new drug application to the US FDA for TLX101-CDx, (Pixclara, ...
22 August 2024 - Clarity Pharmaceuticals is pleased to announce that the US FDA has granted fast track designation for 64Cu-SAR-bisPSMA ...
5 August 2024 - A Phase 3 study for 124I-evuzamitide in patients with suspected cardiac amyloidosis is anticipated to begin ...
1 August 2024 - Polarean Imaging announces that it has submitted a new drug application supplement to the US FDA to ...
1 August 2024 - FDA approval announced earlier this week makes Shield first blood test that is approved for primary screening ...
23 July 2024 - Telix today announces that the US FDA has accepted the filing of its new drug application for ...
3 June 2024 - Telix today announces that it has completed the submission of a biologics license application to the ...
27 May 2024 - Telix Pharmaceuticals today announces it has submitted a new drug application to the US FDA for ...